Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.35 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853589 | 0.91 | HPGD (0.31) | HPGD | |
| SCHEMBL12109920 | 0.85 | HSD11B1 (0.34) | OPRM1OPRD1OPRK1OPRL1MEN1 | |
| SCHEMBL28479357 | 0.84 | CYP2D6 (0.37) | CYP2D6KCNH2OPRM1OPRD1OPRK1 | |
| SCHEMBL9039578 | 0.83 | ESR1 (0.38) | CYP2D6CYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL7534625 | 0.83 | LMNA (0.38) | LMNA | |
| SCHEMBL28687320 | 0.82 | HRH3 (0.42) | MEN1ALDH1A1KMT2A | |
| SCHEMBL23354978 | 0.82 | ACACB (0.35) | — | |
| SCHEMBL17852271 | 0.81 | OPRM1 (0.37) | CYP2D6KCNH2OPRM1OPRD1OPRK1 | |
| SCHEMBL3388839 | 0.80 | MEN1 (0.43) | CYP2D6ADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL12111409 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549291-B | Creep-resistant polypropylene, preparation method thereof and plastic tray | 宁波东拓塑业有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-113549291-A | Creep-resistant polypropylene, preparation method thereof and plastic tray | 宁波东拓塑业有限公司 | 2021-10-26 | — | — | CN | claimed |
| US-20170260312-A1 | PROCESS FOR PRODUCING GRAFT COPOLYMERS ON POLYOLEFIN BACKBONE | BOREALIS AG (AT) | 2017-09-14 | — | — | US | claimed |
| EP-1440099-B8 | VINYLAROMATIC COPOLYMERS MODIFIED WITH (METH) ACRYLONITRILE AND THEIR USE IN A MIXTURE WITH VINYLAROMATIC COPOLYMERS GRAFTED ON RUBBER | POLIMERI EUROPA SPA (IT) | 2008-04-30 | — | — | EP | claimed |
| EP-1440099-B1 | VINYLAROMATIC COPOLYMERS MODIFIED WITH (METH) ACRYLONITRILE AND THEIR USE IN A MIXTURE WITH VINYLAROMATIC COPOLYMERS GRAFTED ON RUBBER | POLIMERI EUROPA SPA (IT) | 2007-11-07 | — | — | EP | claimed |
| US-6906158-B2 | Compositions and methods of vinyl oxazolone polymerization | IRM, LLC (BM) | 2005-06-14 | — | — | US | claimed |
| US-20040242840-A1 | Compositions and methods of vinyl oxazolone polymerization | IRM, LLC | 2004-12-02 | — | — | US | claimed |
| EP-1440099-A1 | VINYLAROMATIC COPOLYMERS MODIFIED WITH MONOMERS DERIVING FROM (METH) ACRYLIC ACID AND THEIR USE IN A MIXTURE WITH VINYLAROMATIC COPOLYMERS GRAFTED ON RUBBER | Polimeri Europa S.r.l. (IT) | 2004-07-28 | — | — | EP | claimed |
| WO-2003029317-A1 | VINYLAROMATIC COPOLYMERS MODIFIED WITH MONOMERS DERIVING FROM (METH) ACRYLIC ACID AND THEIR USE IN A MIXTURE WITH VINYLAROMATIC COPOLYMERS GRAFTED ON RUBBER | POLIMERI EUROPA S.P.A. (IT) | 2003-04-10 | — | — | WO | claimed |
| EP-3532898-B1 | METHOD FOR PRODUCING A POLYMER BY NITROXYL-CONTROLLED POLYMERISATION, AND POLYMER | FRAUNHOFER GES FORSCHUNG (DE) | 2024-07-31 | — | — | EP | disclosed |
| US-11814336-B2 | Oligomeric alkoxy amines | ARKEMA FRANCE (FR) | 2023-11-14 | — | — | US | disclosed |
| US-11814336-B2 | Oligomeric alkoxy amines | ARKEMA FRANCE (FR) | 2023-11-14 | — | — | US | disclosed |
| CN-110100205-B | Method for producing polymers by controlled nitrogen-oxygen polymerization and polymers | 弗劳恩霍夫应用研究促进协会 | 2022-12-30 | — | — | CN | disclosed |
| CN-113549291-B | Creep-resistant polypropylene, preparation method thereof and plastic tray | 宁波东拓塑业有限公司 | 2022-08-16 | — | — | CN | disclosed |
| US-5891971-A | Polymerization processes | XEROX CORPORATION | 1999-04-06 | — | — | US | disclosed |
| EP-0897930-A1 | Polymerization processes | Xerox Corporation (US) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998040415-A1 | IMPROVEMENTS IN ATOM OR GROUP TRANSFER RADICAL POLYMERIZATION | CARNEGIE MELLON UNIVERSITY (US) | 1998-09-17 | — | — | WO | disclosed |
| WO-1998007758-A1 | RATE ENHANCEMENT OF NITROXYL RADICAL-MEDIATED POLYMERIZATION | CARNEGIE MELLON UNIVERSITY (US) | 1998-02-26 | — | — | WO | disclosed |
| US-5677388-A | Difunctional living free radical polymerization initiators | THE DOW CHEMICAL COMPANY (US) | 1997-10-14 | — | — | US | disclosed |
| US-5627248-A | DIFUNCTIONAL NITROXYL INITIATOR | THE DOW CHEMICAL COMPANY (US) | 1997-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814336-B2 | Oligomeric alkoxy amines | ALKBH3, ALK, PNMT | CYP2D6 3433/4885CYP1A2 1882/4885CYP3A4 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.